---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-016685"
form_type: "8-K"
ticker: "IMDX"
cik: "0001642380"
company_name: "Insight Molecular Diagnostics Inc."
filed_at: "2025-10-02T23:59:59+00:00"
generated_at: "2026-05-17T04:56:10.679822+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Insight Molecular grants stock options to four executives, amends CSO employment to indefinite term

## Summary
- Stock options: CEO Riggs 400k shares; CFO James and CSO Schütz 235k each; VP Liu 18k; exercise price $3.33.
- Options vest over 3 years: 1/3 on first anniversary, then monthly over next 2 years, subject to continued service.
- CSO Schütz's employment term amended from fixed 4-year to indefinite until termination; effective Sept 29, 2025.
- Amendment removes references to 'Term Expiration' from severance provisions; all other terms unchanged.

## SEC filing metadata
- accession: 0001493152-25-016685
- form_type: 8-K
- ticker: IMDX
- cik: 0001642380
- company_name: Insight Molecular Diagnostics Inc.
- filed_at: 2025-10-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642380/000149315225016685/0001493152-25-016685-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642380/000149315225016685/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-016685
- JSON: https://secwatch.observer/filing/0001493152-25-016685.json
- Plain text: https://secwatch.observer/filing/0001493152-25-016685.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.